Menu
/REGISTER
Montecito
Giving Guide
PacPremier
Loading...
You are here:  Home  >  Biotech
Latest

Amgen to buy biotech startup TeneoBio

By   /  Tuesday, July 27th, 2021  /  Banking & Finance, Biotech, East Ventura County, Latest news, left, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen to buy biotech startup TeneoBio

Amgen announced July 27 that it plans to buy a privately held Bay Area biotech company called TeneoBio in an all-cash deal worth as much as $2.5 billion. The deal is expected to close in the second half of this year and calls for Amgen to pay $900 million up front for all outstanding shares Read More →

Read More →
Latest

Takeda expansion is latest coup for Conejo Valley pharma industry

By   /  Thursday, July 22nd, 2021  /  Biotech, East Ventura County, Latest news, left, Technology, Top Stories, Tri-County Economy  /  Comments Off on Takeda expansion is latest coup for Conejo Valley pharma industry

Takeda Pharmaceuticals, a Japanese company with major operations in the Conejo Valley, will expand its facility in Thousand Oaks, investing $126 million to build out the manufacturing operations to support new product lines. The Takeda team, alongside the mayor of Thousand Oaks, Claudia Bill-de la Peña, is scheduled to hold a groundbreaking ceremony for the Read More →

Read More →
Latest

FDA accuses Amgen of misleading advertising

By   /  Friday, July 16th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, Top Stories, Tri-County Economy, Tri-County Public Companies  /  No Comments

The U.S. Food and Drug Administration tagged Amgen with a letter July 7 that says the Thousand Oaks biotech firm made “misleading claims” in advertisements for its drug Neulasta, by suggesting it is more effective than biosimilar competitors. Neulasta is a prescription medication used to reduce infection risk from febrile neutropenia (a low level of Read More →

Read More →
Latest

FDA gives Amgen priority review for asthma treatment

By   /  Friday, July 9th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, Top Stories, Tri-County Economy, Tri-County Public Companies  /  No Comments

Thousand Oaks-based Amgen received a priority review for tezepelumab, a treatment for asthma, from the U.S. Food and Drug Administration, the biotech giant announced July 7. According to Amgen, tezepelumab is the first and only biologic to consistently and significantly reduce asthma exacerbations in a broad population of clients in phase 2 and 3 trials. Read More →

Read More →
Latest

Arcutis ends phase 2 trials on potential skin treatment

By   /  Thursday, July 1st, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, Top Stories, Tri-County Economy, Tri-County Public Companies  /  No Comments

Shares of Westlake Village-based Arcutis Biotherapeutics dropped by as much as 5% during the trading day July 1, after the biotech company terminated phase 2 trials for a potential treatment. Arcutis, a biotech company focused on creating dermatology treatments, has announced July that it had terminated phase 2a and 2b trials for evaluating ARQ-252, a Read More →

Read More →
Latest

Biotech’s movers and shakers gather for BioMedley

By   /  Thursday, June 17th, 2021  /  Biotech, Central Coast Health Watch, East Ventura County, Latest news, Subscriber content, Top Stories, Tri-County Economy  /  Comments Off on Biotech’s movers and shakers gather for BioMedley

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen’s new drug could be a blockbuster

By   /  Friday, June 4th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, right, Subscriber content, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen’s new drug could be a blockbuster

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →